Author: da Cunha, Gilmara Franco; de Souza, Fernando Henrique Carlos; Levy-Neto, Maurício; Shinjo, Samuel Katsuyuki
Title: Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis Document date: 2013_5_23
ID: s9mqzqu4_6
Snippet: Study population, clinical assessment and data collection. Between January 1991 and January 2012, 230 consecutive patients with DM or PM and who fulfilled at least four of the five Bohan and Peter (2) criteria were followed at a tertiary hospital. Twenty-four subjects (10.4%) in this group had histories of HZ. Of the remaining patients without HZ, a control group of 48 patients (two controls for every HZ patient) was formed and matched by gender,.....
Document: Study population, clinical assessment and data collection. Between January 1991 and January 2012, 230 consecutive patients with DM or PM and who fulfilled at least four of the five Bohan and Peter (2) criteria were followed at a tertiary hospital. Twenty-four subjects (10.4%) in this group had histories of HZ. Of the remaining patients without HZ, a control group of 48 patients (two controls for every HZ patient) was formed and matched by gender, disease type (DM or PM), age at the onset of myositis and disease duration. The study was approved by the local Research Ethics Committee.
Search related documents:
Co phrase search for related documents- clinical assessment and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- clinical assessment and disease type: 1, 2, 3
- clinical assessment and study population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- clinical assessment and tertiary hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- consecutive patient and disease type: 1
- consecutive patient and study population: 1
- control group and disease myositis: 1
- control group and disease myositis duration: 1
- control group and disease myositis duration onset: 1
- control group and disease myositis duration onset age: 1
- control group and disease type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- control group and group subject: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- control group and remain patient: 1
- control group and study population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- control group and tertiary hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- disease myositis and study population: 1, 2
- disease type and group subject: 1
- disease type and PM DM disease type: 1
Co phrase search for related documents, hyperlinks ordered by date